LexDanaLexDanabeta
Inventor

B. Michael Longenecker

Inventor
Edmonton, CA

Overview

17→
Patents
1990–2015
Patent span
Human necessities
Primary field (CPC A)

Patents· 17 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
C07KPeptides20%
G01NInvestigating or analysing materials by determining their chemical or physical properties16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
Y02ATechnologies for adaptation to climate change7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
C12NMicroorganisms or enzymes4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
Y10TTechnical subjects covered by former us classification2%
PatentTitleYear
9,173,929'Mucinous glycoprotein (MUC-1) vaccine'20159,119,784'Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine'20158,871,250'Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine'20148,552,145'Vaccine for modulating between T1 and T2 immune responses'20138,198,400'Vaccine for modulating between T1 and T2 immune responses'20126,602,660'Methods of detecting T-cell activation'20036,600,012'Lipid-modified muc-1 derivatives'20036,582,697'Enhancement of the cellular immune response'2003RE038046'Enhancement of the cellular immune response'20036,326,009'Enhancement of the cellular immune response'20016,114,129'Methods of detecting T-cell activation and treating disorders associated with T-cell dysfunction'20005,798,090'Enhancement of the cellular immune response'19985,455,332'Carcinoma-marking monoclonal antibodies elicited with synthetic Asialo-GM1 antigen'19955,242,799'Lectin-antibody immunoassays for TF epitope-bearing antigens'19935,110,911'Human tumor-associated Thomsen-Friedenreich antigen'19924,990,326'Method for detecting blood platelets'19914,971,795'Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype'1990

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1990–2003Patents assigned to BIOMIRA INC (10)· patent assignee history
1990–2015Based in Edmonton, CA· patent location history
2000–2014Based in Alberta, CA· patent location history
2012–2015Patents assigned to ONCOTHYREON INC (5)· patent assignee history
2012–2015Patents assigned to LONGENECKER B MICHAEL (4)· patent assignee history
2012–2013Patents assigned to BUDZYNSKI WLADYSLAW A (2)· patent assignee history
2012–2013Patents assigned to KOGANTY R RAO (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BIOMIRA INC101990–2003
ONCOTHYREON INC52012–2015
LONGENECKER B MICHAELself42012–2015
BUDZYNSKI WLADYSLAW A22012–2013
KOGANTY R RAO22012–2013
Locations
LocationPatentsSpan
Edmonton, CA151990–2015
Alberta, CA22000–2014